• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用与液-液相分离相关的长链非编码RNA预测前列腺癌的预后和治疗反应。

Utilizing Liquid-liquid phase separation-related lncRNAs to predict the prognosis and treatment response of PCa.

作者信息

Qiu Jiangping, Lai Cong, Yuan Zhihan, Hu Jintao, Wu Jiang, Liu Cheng, Xu Kewei

机构信息

Shenshan Medical Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, No.1 Zhanqian Heng'er Road, Dongchong Town, Shanwei City, 516621, Guangdong, China.

Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, No.107 Yanjiang West Road, Guangzhou, 510000, Guangdong, China.

出版信息

Discov Oncol. 2024 Aug 16;15(1):352. doi: 10.1007/s12672-024-01226-3.

DOI:10.1007/s12672-024-01226-3
PMID:39150479
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11329450/
Abstract

BACKGROUND

Studies have indicated a close association between genes linked to liquid-liquid phase separation (LLPS) and the progression of prostate cancer (PCa). However, the interplay among long non-coding RNAs (lncRNAs) linked to LLPS in PCa remains elusive. Therefore, we constructed a prediction model based on LLPS-related LncRNA in PCa to explore its relationship with the prognosis and drug treatment of PCa.

METHODS

We obtained clinical and sequencing data from TCGA and LLPS genes from the Phase Separation Protein Database. By analyzing the differential expression of LLPS-related genes and lncRNAs in prostate cancer, and using Poisson correlation, we identified LLPS-related lncRNAs. Prognostic LLPS-lncRNAs were found through prognostic correlation analysis and included in a Cox model to compute regression coefficients. Patients were scored and divided into high- and low-risk groups. Independent prognostic factors were integrated into a prognostic nomogram with risk and Gleason scores. We also conducted drug sensitivity analyses, GSEA, and validated the impact of key lncRNAs through functional experiments.

RESULTS

Our study identified five LLPS-associated lncRNAs that are of prognostic importance. And found notable disparities in biochemical recurrence rates and survival outcomes between these risk groups, with the low-risk cohort exhibiting superior prognostic indicators. Moreover, our prediction nomogram demonstrated robust predictive accuracy and significant clinical utility. Furthermore, our model exhibited promising capabilities in forecasting patient sensitivity to various conventional therapeutic drugs, thereby highlighting its potential in personalized treatment strategies. GSEA showed that these lncRNAs may influence PCa prognosis and sensitivity to therapeutic agents by affecting pathways such as cell cycle. Knockdown of AC009812.4 could inhibit the ability of PCa cells to proliferate, migrate and invade, and compare to paracancerous tissue, AC009812.4 in PCa tissue has significantly higher expression.

CONCLUSION

Our research uncovers the prognostic significance of lncRNAs associated with LLPS in PCa and established a model exhibiting excellent predictive accuracy for prognosis. Those lncRNAs may influence progress of PCa as well as sensitivity to therapy drugs through pathways such as cell cycle.

摘要

背景

研究表明,与液-液相分离(LLPS)相关的基因与前列腺癌(PCa)的进展密切相关。然而,PCa中与LLPS相关的长链非编码RNA(lncRNA)之间的相互作用仍不清楚。因此,我们构建了基于PCa中LLPS相关lncRNA的预测模型,以探讨其与PCa预后和药物治疗的关系。

方法

我们从TCGA获得临床和测序数据,并从相分离蛋白数据库获得LLPS基因。通过分析前列腺癌中LLPS相关基因和lncRNA的差异表达,并使用泊松相关性,我们鉴定了LLPS相关lncRNA。通过预后相关性分析发现预后性LLPS-lncRNA,并将其纳入Cox模型以计算回归系数。对患者进行评分并分为高风险和低风险组。将独立预后因素与风险和Gleason评分整合到预后列线图中。我们还进行了药物敏感性分析、基因集富集分析(GSEA),并通过功能实验验证了关键lncRNA的影响。

结果

我们的研究鉴定了五个具有预后重要性的LLPS相关lncRNA。并且发现这些风险组之间在生化复发率和生存结果方面存在显著差异,低风险队列表现出更好的预后指标。此外,我们的预测列线图显示出强大的预测准确性和显著的临床实用性。此外,我们的模型在预测患者对各种传统治疗药物的敏感性方面表现出有前景的能力,从而突出了其在个性化治疗策略中的潜力。GSEA表明,这些lncRNA可能通过影响细胞周期等途径影响PCa的预后和对治疗药物的敏感性。敲低AC009812.4可抑制PCa细胞的增殖、迁移和侵袭能力,并且与癌旁组织相比,PCa组织中AC009812.4的表达明显更高。

结论

我们的研究揭示了PCa中与LLPS相关的lncRNA的预后意义,并建立了一个对预后具有出色预测准确性的模型。这些lncRNA可能通过细胞周期等途径影响PCa的进展以及对治疗药物的敏感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b0f/11329450/8f9358b609f7/12672_2024_1226_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b0f/11329450/6ca65b078ae6/12672_2024_1226_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b0f/11329450/6cf00edc2857/12672_2024_1226_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b0f/11329450/4bdee8b404a7/12672_2024_1226_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b0f/11329450/0b3c9b5a4cb2/12672_2024_1226_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b0f/11329450/158b443ae2d7/12672_2024_1226_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b0f/11329450/20ddbbb40017/12672_2024_1226_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b0f/11329450/8f9358b609f7/12672_2024_1226_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b0f/11329450/6ca65b078ae6/12672_2024_1226_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b0f/11329450/6cf00edc2857/12672_2024_1226_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b0f/11329450/4bdee8b404a7/12672_2024_1226_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b0f/11329450/0b3c9b5a4cb2/12672_2024_1226_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b0f/11329450/158b443ae2d7/12672_2024_1226_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b0f/11329450/20ddbbb40017/12672_2024_1226_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b0f/11329450/8f9358b609f7/12672_2024_1226_Fig7_HTML.jpg

相似文献

1
Utilizing Liquid-liquid phase separation-related lncRNAs to predict the prognosis and treatment response of PCa.利用与液-液相分离相关的长链非编码RNA预测前列腺癌的预后和治疗反应。
Discov Oncol. 2024 Aug 16;15(1):352. doi: 10.1007/s12672-024-01226-3.
2
Liquid-liquid phase separation-related lncRNA prognostic signature and ZNF32-AS2 as a novel biomarker in hepatocellular carcinoma.液-液相分离相关长链非编码 RNA 预后 signature 及 ZNF32-AS2 作为肝细胞癌的新型标志物。
Comput Biol Med. 2024 Feb;169:107975. doi: 10.1016/j.compbiomed.2024.107975. Epub 2024 Jan 6.
3
A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer.一种与铜死亡相关的长链非编码RNA特征:前列腺癌生化复发及免疫微环境的综合分析
Front Genet. 2023 Feb 24;14:1096783. doi: 10.3389/fgene.2023.1096783. eCollection 2023.
4
A Liquid-Liquid Phase Separation-Related Index Associate with Biochemical Recurrence and Tumor Immune Environment of Prostate Cancer Patients.与前列腺癌患者生化复发及肿瘤免疫环境相关的液-液相分离相关指数。
Int J Mol Sci. 2023 Mar 14;24(6):5515. doi: 10.3390/ijms24065515.
5
Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer.一种新的明确的炎症相关长链非编码RNA特征的鉴定有助于预测膀胱癌的预后以及区分冷肿瘤和热肿瘤。
Front Oncol. 2023 Mar 29;13:972558. doi: 10.3389/fonc.2023.972558. eCollection 2023.
6
Integrated Bioinformatics and Experimental Validation to Identify a Disulfidptosis-Related lncRNA Model for Prognostic Prediction in Papillary Renal Cell Carcinoma.整合生物信息学与实验验证以鉴定用于乳头状肾细胞癌预后预测的二硫化物化相关lncRNA模型
Comb Chem High Throughput Screen. 2025;28(5):883-898. doi: 10.2174/0113862073303084240403051346.
7
Establishment of a prognostic risk prediction model incorporating disulfidptosis-related lncRNA for patients with prostate cancer.建立一个包含二硫键相关 lncRNA 的前列腺癌患者预后风险预测模型。
BMC Cancer. 2024 Jan 8;24(1):44. doi: 10.1186/s12885-023-11778-2.
8
A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma.铜死亡相关长链非编码 RNA 风险模型预测肝细胞癌患者的预后和免疫治疗疗效。
Biochem Genet. 2024 Jun;62(3):2332-2351. doi: 10.1007/s10528-023-10539-x. Epub 2023 Oct 29.
9
Construction of a prognostic model of colon cancer patients based on metabolism-related lncRNAs.基于代谢相关长链非编码RNA构建结肠癌患者预后模型
Front Oncol. 2022 Sep 29;12:944476. doi: 10.3389/fonc.2022.944476. eCollection 2022.
10
A Prognostic Model of Bladder Cancer Based on Metabolism-Related Long Non-Coding RNAs.基于代谢相关长链非编码RNA的膀胱癌预后模型
Front Oncol. 2022 Feb 25;12:833763. doi: 10.3389/fonc.2022.833763. eCollection 2022.

本文引用的文献

1
Establishment of a prognostic risk prediction model incorporating disulfidptosis-related lncRNA for patients with prostate cancer.建立一个包含二硫键相关 lncRNA 的前列腺癌患者预后风险预测模型。
BMC Cancer. 2024 Jan 8;24(1):44. doi: 10.1186/s12885-023-11778-2.
2
Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification.根治性治疗后前列腺癌患者的生化复发:基于风险分层的治疗。
Prostate Cancer Prostatic Dis. 2024 Jun;27(2):192-201. doi: 10.1038/s41391-023-00712-z. Epub 2023 Sep 7.
3
The role of long noncoding RNAs in liquid-liquid phase separation.
长链非编码RNA在液-液相分离中的作用。
Cell Signal. 2023 Nov;111:110848. doi: 10.1016/j.cellsig.2023.110848. Epub 2023 Aug 7.
4
A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer.一种与铜死亡相关的长链非编码RNA特征:前列腺癌生化复发及免疫微环境的综合分析
Front Genet. 2023 Feb 24;14:1096783. doi: 10.3389/fgene.2023.1096783. eCollection 2023.
5
Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches.前列腺癌综述:遗传学、诊断、治疗选择和替代方法。
Molecules. 2022 Sep 5;27(17):5730. doi: 10.3390/molecules27175730.
6
Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention.长链非编码 RNA 在前列腺癌中的分子特征:干预途径和治疗靶点的关注。
J Exp Clin Cancer Res. 2022 Jul 1;41(1):214. doi: 10.1186/s13046-022-02406-1.
7
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials.靶向前列腺癌中的信号通路:机制与临床试验。
Signal Transduct Target Ther. 2022 Jun 24;7(1):198. doi: 10.1038/s41392-022-01042-7.
8
Expression status and prognostic value of autophagy-related lncRNAs in prostate cancer.自噬相关长链非编码 RNA 在前列腺癌中的表达状态及预后价值。
Cell Cycle. 2022 Aug;21(16):1684-1696. doi: 10.1080/15384101.2022.2065149. Epub 2022 Apr 24.
9
TFAP2C-Mediated lncRNA PCAT1 Inhibits Ferroptosis in Docetaxel-Resistant Prostate Cancer Through c-Myc/miR-25-3p/SLC7A11 Signaling.TFAP2C介导的lncRNA PCAT1通过c-Myc/miR-25-3p/SLC7A11信号通路抑制多西他赛耐药前列腺癌中的铁死亡
Front Oncol. 2022 Mar 23;12:862015. doi: 10.3389/fonc.2022.862015. eCollection 2022.
10
A Prognostic Model of Bladder Cancer Based on Metabolism-Related Long Non-Coding RNAs.基于代谢相关长链非编码RNA的膀胱癌预后模型
Front Oncol. 2022 Feb 25;12:833763. doi: 10.3389/fonc.2022.833763. eCollection 2022.